EP 0854710 A2 19980729 - USE OF A -g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE
Title (en)
USE OF A -g(g)-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE
Title (de)
VERWENDUNG VON EINEM RAR-GAMMA-SPEZIFISCHEN AGONISTISCHEN LIGAND ZUR FÖRDERUNG DER APOPTOSE
Title (fr)
UTILISATION D'UN LIGAND AGONISTE SPECIFIQUE RAR--g(g) POUR AUGMENTER LE TAUX D'APOPTOSE
Publication
Application
Priority
- FR 9601568 W 19961008
- FR 9512179 A 19951009
Abstract (en)
[origin: US2001018456A1] A method for increasing the rate of apoptosis in at least one cell population in which apoptosis is induced by activating receptors of the RAR-gamma type, the method comprising exposing the cell population to an effective amount of at least one agonist ligand which is specific for receptors of the RAR-gamma type to increase the rate of apoptosis.
IPC 1-7
A61K 31/19; A61K 31/34; A61K 31/35; A61K 31/38; A61K 31/40; A61K 31/60
IPC 8 full level
C07D 333/38 (2006.01); A61K 8/00 (2006.01); A61K 8/36 (2006.01); A61K 8/368 (2006.01); A61K 8/40 (2006.01); A61K 8/41 (2006.01); A61K 8/46 (2006.01); A61K 8/49 (2006.01); A61K 31/19 (2006.01); A61K 31/192 (2006.01); A61K 31/195 (2006.01); A61K 31/34 (2006.01); A61K 31/343 (2006.01); A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61K 31/40 (2006.01); A61K 31/60 (2006.01); A61K 45/00 (2006.01); A61P 1/16 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 29/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 207/34 (2006.01); C07D 307/91 (2006.01); C07D 311/58 (2006.01)
CPC (source: EP KR US)
A61K 31/19 (2013.01 - KR); A61K 31/192 (2013.01 - EP US); A61P 1/16 (2017.12 - EP); A61P 3/08 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 9713505A2
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 2001018456 A1 20010830; AU 705993 B2 19990603; AU 7220996 A 19970430; BR 9610967 A 19990302; CA 2231561 A1 19970417; CN 1121857 C 20030924; CN 1203528 A 19981230; EP 0854710 A2 19980729; FR 2739557 A1 19970411; FR 2739557 B1 19971114; HU P9900453 A2 19990528; HU P9900453 A3 19991129; JP 3135266 B2 20010213; JP H11501661 A 19990209; KR 19990064139 A 19990726; NO 981592 D0 19980407; NO 981592 L 19980609; NZ 319646 A 20000825; PL 185826 B1 20030829; PL 326077 A1 19980817; RU 2188037 C2 20020827; TR 199800645 T1 19980622; US 6506796 B1 20030114; US 6593359 B1 20030715; US 6686386 B1 20040203; WO 9713505 A2 19970417; WO 9713505 A3 19970529
DOCDB simple family (application)
US 80166401 A 20010309; AU 7220996 A 19961008; BR 9610967 A 19961008; CA 2231561 A 19961008; CN 96198769 A 19961008; EP 96933502 A 19961008; FR 9512179 A 19951009; FR 9601568 W 19961008; HU P9900453 A 19961008; JP 51476797 A 19961008; KR 19980702620 A 19980409; NO 981592 A 19980407; NZ 31964696 A 19961008; PL 32607796 A 19961008; RU 98108590 A 19961008; TR 9800645 T 19961008; US 43192099 A 19991102; US 5140798 A 19980715; US 62477100 A 20000725